George Clinical’s senior management team bring together unique and innovative qualities that make us a key partner in clinical research programs. Our team combines significant scientific and medical knowledge as well as the operational expertise developed through decades of working in clinical research, pharmaceutical companies, medical device companies and CROs.
Marisa Petersen, PhD
Chief Executive Officer, George Clinical
Marisa completed her pharmacy degree at the University of Sydney and continued her studies with a PhD in Clinical Pharmacology and Pharmacokinetics. She has worked for over 20 years in the pharmaceutical industry, fulfilling roles in Regulatory Affairs, Clinical Research and Project Management. Prior to joining George Clinical, Marisa was the Vice President Asia Pacific for Omnicare Clinical Research, a global CRO, taking responsibility for the delivery of trials in the Asia-Pacific region and developing a network of offices across the region to effectively service customer needs. In her current role, Marisa is focussed on sustainable growth of resources in the region and delivery of regional and global studies to the highest international standards. Marisa has a strong association with ARCS in Australia and Asia and is a member of the Australian R&D Taskforce.
Amanda Jubb, BSc (Hons)
Global Head, Project Operations
Amanda is responsible for the project management and clinical operations teams to deliver our studies to the highest standards. Amanda has over 20 years’ experience implementing clinical trials across the Asia Pacific region and more than 15 years line management experience. Her previous management roles span both CROs and pharmaceutical companies and she has worked as an independent consultant.
Deborah Fox, BPharm G.Dip App. Sc. (Info)
Global Head, Clinical Research Compliance
Deb oversees all compliance, training and regulatory functions. Deb has more than 20 years clinical research experience in the Pharmaceutical Industry having worked across the broader Asia Pacific region. Her previous roles and responsibilities have included project and site management, clinical operations, clinical quality assurance/auditing, management of safety reporting, compliance and training activities and line management of staff, and is supplemented by extensive prior experience as a hospital pharmacist across a wide range of therapeutic areas. Deb has worked for a variety of major pharmaceutical companies and contract research organizations.
Global Head, Data Management and Project Systems
Paul manages the data management team delivering support for the various research projects conducted; including clinical trials, observational studies and surveys. Paul has over 20 years experience with global pharmaceutical and CRO companies, focusing primarily on Data Management and Project Management. Paul has worked extensively in all phases of clinical studies, from Phase I – IV and has worked collaboratively with organizations in Europe, North America and Asia. Previously, Paul has held senior positions at Roche, Novartis, PRA International and Quintiles.
Jacqueline Thorn, PhD MBA GDip IP
Commercial Director and Head of Business Operations ANZ
Jacqueline manages proposals and pricing, contracting, risk management and strategic partnerships for George Clinical’s global business. Jacqueline has extensive experience in business development having spent 20 years in the healthcare industry working in the biotechnology, diagnostic and pharmaceutical markets. She held various sales, marketing and business development positions and has experience in intellectual property management.
Maria Ali, MBBS, MBA
Global Head, Medical, Regulatory Services and Scientific Leadership
Maria leads the Medical and Safety Services group at George Clinical that provides safety management, endpoint adjudication, medical monitoring and scientific leadership for both commercially sponsored and academic clinical trials. Maria’s group has extensive experience in delivering these services for trials in all phases of clinical studies (Phase I – IV) as well as a variety of collaborative settings. Maria works closely with the scientific leads at George Institute to develop and implement scientific leadership models for George Clinical studies, as well as to develop new ideas for clinical research, and processes to improve clinical trial design and efficiencies. Maria has several years’ experience in both public health and clinical research, and research management, across a range of settings including hospitals, academic and clinical research organizations.
Global Head, Biometrics and Technology Solutions
Jeff completed his degrees (BS) in engineering (Aerospace as well as Mechanical) at the University of Missouri – Rolla in 1992. Instead of the engineering field, Jeff pursued pharmaceutical research from 1993 onward. For over 22 years, Jeff led the clinical data management group as well as statistics, statistical programming, medical writing, and IT infrastructure and development at United BioSource Corporation. This group grew over the years from one location and 3 employees in 1993 to 4 locations and over 100 employees within the data management and biostats groups. Jeff has focused on systems development and programming throughout his career with an emphasis on CTMS, EDC, EMR, as well as other electronic systems focused on improving clinical care and research.
Philip Gregory BSc. (Hons)
Managing Director, China
Philip has over 22 years’ experience in Pharmaceutical marketing in mainstream pharmaceutical companies, biotechnology and medical devices. He has held senior management roles in International marketing, brand and business development and strategic portfolio development. Philip has worked in several countries including the USA, UK, Japan, Australia and China and has worked in Asia for over 15 years, the last seven years in China. Philip is the Managing Director of George Clinical China and oversees the next stages in the development of George Clinical’s business and operations in China and to support the growth of our clinical research activities across the Asia-Pacific Region.
Managing Director, India
Vanaja has a Master’s degree in Commerce and professional qualifications in both Cost & Financial managementand Corporate compliance. She has 25 years of experience in Global Organizations such as Molex Inc. & Sigma Aldrich (now a subsidiary of Merck) as CFO and other Senior Leadership roles in Finance, Human Resources, Information Systems and Sourcing & Procurement. Most recently Vanaja was responsible for establishing and leading Global Shared Services for Sigma Aldrich. Vanaja has significant experience leading major strategic projects through to completion. Vanaja in her role as Managing Director in India oversees the India business, focusing on its growth strategy and expansion of George Clinical’s footprint in India’s Clinical Research landscape.
Head of Business Operations, East Asia
Evon has completed her Bachelor of Science Degree in Biology at the University of Toronto and continued her Master’s studies in Nutritional Science. She has over 15 year of experience working in the pharmaceutical industry in various fields including regulatory affairs, clinical research and project management. Prior to joining George Clinical, Evon held a clinical operations management role at Pfizer. Evon is the Associate Director of Business Operations at George Clinical managing the business activities in various countries in East Asia including Hong Kong, Malaysia, Philippines, South Korea, Taiwan, Thailand and Vietnam. Evon also oversees the next stages in the development of George Clinical’s business and operations in other Asia-Pacific Region.
Managing Director USA and Global Head of Late Phase Studies
Sean Hart is the Managing Director USA and Global Head of Late Phase Studies for George Clinical. Prior to joining George Clinical, Sean was the Executive Vice President and Managing Director of Vector Oncology overseeing the Global Pharma Services team including early phase and observational research. Sean is a recognized industry leader in Phase IV clinical trials, post-marketing surveillance programs, and patient registries. His experience spans all major therapeutic areas and all phases of research and development.